These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 17441890)

  • 1. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
    Vural B; Ozkan S; Bodur H
    J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased level of prostate-specific antigen: a diagnostic marker of hyperandrogenism women].
    Wang GH; Xu RJ; Zhang ZS
    Zhonghua Nan Ke Xue; 2009 Nov; 15(11):1028-30. PubMed ID: 20218317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study.
    Celik O; Sahin I; Celik N; Hascalik S; Keskin L; Ozcan H; Uckan A; Kosar F
    Hum Reprod; 2007 Nov; 22(11):2992-8. PubMed ID: 17855407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
    Mitkov M; Pehlivanov B; Orbetzova M
    Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M; Orbtsova M; Terzieva D
    Akush Ginekol (Sofiia); 2008; 47(3):15-9. PubMed ID: 18756827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
    Noyan V; Yucel A; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
    Sills ES; Drews CD; Perloe M; Tucker MJ; Kaplan CR; Palermo GD
    Gynecol Endocrinol; 2003 Jun; 17(3):231-7. PubMed ID: 12857431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
    Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
    Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.